Summary of Significant Accounting Policies (Details) (USD $)	12 Months Ended	94 Months Ended
Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2014
Antidilutive Securities Excluded and Imapirment charges
Research and development cost	$ 364,095us-gaap_ResearchAndDevelopmentExpense	$ 459,651us-gaap_ResearchAndDevelopmentExpense	$ 4,152,640us-gaap_ResearchAndDevelopmentExpense
Number of warrants excluded from weighted average common shares outstanding on a diluted basis.	5,586,000	7,586,000
Number of options excluded from weighted average common shares outstanding on a diluted basis.	2,750,000	2,750,000

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details